| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from private placement-Private Placement Offering Four Twenty Twenty Five | 694,999 | 694,999 |
| Proceeds from at-the-market offering | 6,781,236 | 3,001,985 |
| Payment of offering transactions costs | 498,429 | 381,293 |
| Net cash provided by financing activities | 13,104,175 | 8,869,406 |
| Net effect of foreign currency exchange on cash | 10,390 | 11,429 |
| Net increase in cash | 1,290,438 | 543,224 |
| Cash and cash equivalents at beginning of period | 9,601,298 | - |
| Cash and cash equivalents at end of period | 10,891,736 | - |
MAIA Biotechnology, Inc. (MAIA)
MAIA Biotechnology, Inc. (MAIA)